Replies to post #258644 on Avid Bioservices Inc (CDMO)

[eb0783]

I agree that Peregrine has done much better than the average BP/biotech. Was this comment an attempt to be disparaging to Peregrine or a try to make us think Peregrine is worse than most BPs/biotechs, a terrible company?:

This company has lost over one half billion

Really this should bring it home to us:

A new report published by the Tufts Center for the Study of Drug Development (CSDD) pegs the cost of developing a prescription drug that gains market approval at $2.6 billion

Again, I agree that Peregrine has done much better than the average BP/biotech. C'mon man!

[eb0783]

So are you pointing out how much better they have done with their expenses than the average BP/biotech or are you trying to say that this is a terrible company?

This company has lost over one half billion and going strong

Because

BOSTON – Nov. 18, 2014 – Developing a new prescription medicine that gains marketing approval, a process often lasting longer than a decade, is estimated to cost $2,558 million, according to a new study by the Tufts Center for the Study of Drug Development.